Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1 H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases

Details for Australian Patent Application No. 2008224657 (hide)

Owner Cancer Research Technology Limited Astex Therapeutics Limited The Institute of Cancer Research:Royal Cancer Hospital

Inventors Rees, David Charles; Grimshaw, Kyla Merriom; Frederickson, Martyn; Woodhead, Steven John

Agent Davies Collison Cave

Pub. Number AU-A-2008224657

PCT Pub. Number WO2008/110846

Priority 60/894,752 14.03.07 US; 0704932.3 14.03.07 GB

Filing date 14 March 2008

Wipo publication date 18 September 2008

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 301/00 (2006.01) Heterocyclic compounds having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as ring hetero atoms

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

24 September 2009 PCT application entered the National Phase

  PCT publication WO2008/110846 Priority application(s): WO2008/110846

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008224662-Production of solid bio-fuel from cynara. cardunculus (wild artichoke) cultivation

2008224651-Beneficial effects of bacteriophage treatments